Breo Ellipta (Fluticasone Vilanterol)

Description

What is Breo Ellipta?

Breo Ellipta is an inhalation powder that combines two active ingredients: fluticasone propionate, a corticosteroid, and vilanterol, a long-acting beta-agonist (LABA). It is primarily used to control and prevent asthma symptoms and manage COPD by reducing inflammation and relaxing the muscles around the airways.

How does Breo Ellipta work in the body?

Breo Ellipta works through its two components:

• Fluticasone: Reduces inflammation in the airways, helping to prevent asthma attacks and improve overall lung function.
• Vilanterol: Relaxes the muscles around the airways, allowing for easier breathing and providing prolonged relief from bronchospasm.

Who is Breo Ellipta for?

Breo Ellipta is intended for individuals with asthma or COPD who require regular treatment to manage their symptoms. Candidates for Breo therapy include:

• Individuals with Persistent Asthma: Those who need both a corticosteroid and a long-acting bronchodilator.
• Patients with COPD: Individuals experiencing chronic respiratory symptoms who require bronchodilation.

What are the benefits of using Breo Ellipta?

• Effective Symptom Control: Provides significant relief from wheezing, shortness of breath, and other respiratory symptoms.
• Long-Term Management: Helps prevent asthma attacks and manage chronic obstructive pulmonary disease over time.
• Convenient Dosing: Administered via an easy-to-use Ellipta inhaler, allowing for quick delivery of medication.

What are the side effects of Breo Ellipta?

While effective, Breo Ellipta may cause side effects in some individuals. Common side effects include:

• Throat Irritation: Some users may experience irritation or dryness in the throat.
• Headaches: Headaches are a common side effect associated with inhaled medications.
• Increased Heart Rate: Vilanterol can cause an increase in heart rate in some individuals.
• Coughing or Hoarseness: Users may experience coughing or changes in voice.

How should Breo Ellipta be taken / dosage information?

Breo Ellipta is typically taken using the inhaler device. Key dosage information includes:

• Recommended Dose: The usual starting dose is one inhalation of 100/25 mcg or 200/25 mcg once daily, depending on individual needs and severity of symptoms.
• Administration: It is important to follow specific instructions for inhalation technique to ensure effective delivery of medication.

Who should avoid taking Breo Ellipta?

Certain individuals should avoid using Breo Ellipta:

• History of Allergic Reactions: Those with known hypersensitivity to fluticasone or vilanterol should avoid this medication.
• Severe Asthma Attacks: Individuals experiencing acute asthma attacks should not use this as a rescue inhaler.